DE69837935D1 - Nukleotid- und proteinsequenz von mammastatin und anwendungsmethoden - Google Patents

Nukleotid- und proteinsequenz von mammastatin und anwendungsmethoden

Info

Publication number
DE69837935D1
DE69837935D1 DE69837935T DE69837935T DE69837935D1 DE 69837935 D1 DE69837935 D1 DE 69837935D1 DE 69837935 T DE69837935 T DE 69837935T DE 69837935 T DE69837935 T DE 69837935T DE 69837935 D1 DE69837935 D1 DE 69837935D1
Authority
DE
Germany
Prior art keywords
kda
mammastatin
phosphorylated
mammary
express
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69837935T
Other languages
English (en)
Other versions
DE69837935T2 (de
Inventor
Paul R Ervin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Michigan
Original Assignee
University of Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Michigan filed Critical University of Michigan
Application granted granted Critical
Publication of DE69837935D1 publication Critical patent/DE69837935D1/de
Publication of DE69837935T2 publication Critical patent/DE69837935T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/74—Inducing cell proliferation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69837935T 1997-12-19 1998-12-18 Nukleotid- und proteinsequenz von mammastatin und anwendungsmethoden Expired - Lifetime DE69837935T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/994,076 US6500937B1 (en) 1996-10-03 1997-12-19 Nucleotide sequence encoding a mammary cell growth inhibitor
US994076 1997-12-19
PCT/US1998/027147 WO1999032625A2 (en) 1997-12-19 1998-12-18 Nucleotide and protein sequence of mammastatin and methods of use

Publications (2)

Publication Number Publication Date
DE69837935D1 true DE69837935D1 (de) 2007-07-26
DE69837935T2 DE69837935T2 (de) 2008-02-21

Family

ID=25540260

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69837935T Expired - Lifetime DE69837935T2 (de) 1997-12-19 1998-12-18 Nukleotid- und proteinsequenz von mammastatin und anwendungsmethoden

Country Status (8)

Country Link
US (5) US6500937B1 (de)
EP (1) EP1037989B1 (de)
JP (1) JP4441113B2 (de)
AT (1) ATE364706T1 (de)
AU (1) AU1935399A (de)
CA (1) CA2315239C (de)
DE (1) DE69837935T2 (de)
WO (1) WO1999032625A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4452331B2 (ja) * 1996-10-03 2010-04-21 ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミシガン ママスタチンのヌクレオチドおよびタンパク質配列およびその使用法
US6500937B1 (en) * 1996-10-03 2002-12-31 University Of Michigan Nucleotide sequence encoding a mammary cell growth inhibitor
US6939714B2 (en) 1999-06-18 2005-09-06 Biotherapies, Inc. Epithelial cell growth inhibitors
EP1190054A1 (de) * 1999-06-18 2002-03-27 Biotherapies, Inc. Epithelzellenwachstumsinhibitor
AU6583700A (en) * 1999-08-13 2001-03-13 Oxford Glycosciences (Uk) Limited Proteins, genes and their use for diagnosis and treatment of breast cancer
WO2001046697A2 (en) * 1999-12-21 2001-06-28 Millennium Predictive Medicine Identification, assessment, prevention, and therapy of breast cancer
WO2001071357A2 (en) * 2000-03-20 2001-09-27 Oxford Glycosciences (Uk) Limited Diagnosis and treatment of breast cancer
US20030212263A1 (en) * 2000-06-19 2003-11-13 The University Of Michigan Mammastatin sequence variant C
WO2002088750A2 (en) * 2001-05-02 2002-11-07 Oxford Glycosciences (Uk) Ltd Proteins, genes and their use for diagnosis and treatment of breast cancer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4379839A (en) 1977-05-23 1983-04-12 The Trustees Of Columbia University In The City Of New York Method for detecting cancer
US4753894A (en) 1984-02-08 1988-06-28 Cetus Corporation Monoclonal anti-human breast cancer antibodies
WO1989011491A1 (en) 1988-05-20 1989-11-30 The Regents Of The University Of Michigan Antibodies to human mammary cell growth inhibitor and methods of production and use
WO1989011492A1 (en) 1988-05-20 1989-11-30 The Regents Of The University Of Michigan Human mammary cell growth inhibitor and methods of production and use
US5878385A (en) * 1996-09-16 1999-03-02 Ergo Linguistic Technologies Method and apparatus for universal parsing of language
JP4452331B2 (ja) * 1996-10-03 2010-04-21 ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミシガン ママスタチンのヌクレオチドおよびタンパク質配列およびその使用法
US6500937B1 (en) * 1996-10-03 2002-12-31 University Of Michigan Nucleotide sequence encoding a mammary cell growth inhibitor
EP1190054A1 (de) 1999-06-18 2002-03-27 Biotherapies, Inc. Epithelzellenwachstumsinhibitor

Also Published As

Publication number Publication date
WO1999032625A2 (en) 1999-07-01
US7816097B2 (en) 2010-10-19
US6599495B1 (en) 2003-07-29
US20080207506A1 (en) 2008-08-28
DE69837935T2 (de) 2008-02-21
WO1999032625A3 (en) 1999-09-16
EP1037989A2 (de) 2000-09-27
JP4441113B2 (ja) 2010-03-31
US20110003318A1 (en) 2011-01-06
AU1935399A (en) 1999-07-12
US6500937B1 (en) 2002-12-31
US20070082334A1 (en) 2007-04-12
ATE364706T1 (de) 2007-07-15
CA2315239C (en) 2008-05-13
US7256277B2 (en) 2007-08-14
CA2315239A1 (en) 1999-07-01
EP1037989B1 (de) 2007-06-13
JP2001526891A (ja) 2001-12-25

Similar Documents

Publication Publication Date Title
DE69131580T2 (de) GDF-1 und UOG1 Proteine
PT101297A (pt) Factores mitogenicos gliais, sua preparacao e utilizacao
ATE352626T1 (de) Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren
DK1025211T3 (da) Hyaluronansyntasegen og anvendelser deraf
PT917571E (pt) Gene relacionado com agouti
DK1007537T3 (da) Receptor-protein med betegnelsen 2F1
WO2000075350A3 (en) Nucleic acid sequences encoding proteins involved in fatty acid beta-oxidation and methods of use
HUP9900868A2 (hu) Heterológ gének kromoszomális expressziója bakteriális sejtekben
DE68910279D1 (de) Hydroxyfunktionelle Monomere, ihre Herstellung sowie ihre Verwendung zur Herstellung von Polyurethanen.
NZ510356A (en) Molecules designated LDCAM
DE69334211D1 (de) Multidrug resistenz gen
DE69837935D1 (de) Nukleotid- und proteinsequenz von mammastatin und anwendungsmethoden
IT8921243A0 (it) Nuovi geni ibridi funzionali di bacillus thuringiensis ottenuti mediante ricombinazione in vivo.
NO853012L (no) Nye genetiske sekvenser, interfenonpeptider av type i uttrykt av disse og organismer som produserer dem.
DK1082423T3 (da) Cyclin E2-gener og -proteiner
DE68902192T2 (de) Ethylenthioharnstoff enthaltende zusammensetzungen zur herstellung von verschleissfesten, stromlos abgeschiedenen nickel-borueberzuegen.
FR2710074B1 (fr) Gène GRB3-3, ses variants et leurs utilisations.
WO1998014577A3 (en) Nucleotide and protein sequence of mammastatin and methods of use
ATE214427T1 (de) Chimäre msp und daf proteine mit einem telloberflächenlokalisierendem domän
WO2000008157A3 (en) Human anion transporter genes atnov
WO1999047709A3 (en) Methods for identifying anti-cancer agents
ATE402258T1 (de) Gene differentiell experimiert in brudtkrebs
CA2284100A1 (en) New gene with upregulated expression in metastatic human tumor cells and a protein coded thereby, methods of production, and use thereof
ES8705466A1 (es) Un metodo para la preparacion del factor nkbs regulador del cancer humano.
CA2260756A1 (en) System for genetically treating cardiac conduction disturbances

Legal Events

Date Code Title Description
8364 No opposition during term of opposition